[go: up one dir, main page]

UA99094C2 - Способ лечения пациента с системной красной волчанкой - Google Patents

Способ лечения пациента с системной красной волчанкой

Info

Publication number
UA99094C2
UA99094C2 UAA200806028A UAA200806028A UA99094C2 UA 99094 C2 UA99094 C2 UA 99094C2 UA A200806028 A UAA200806028 A UA A200806028A UA A200806028 A UAA200806028 A UA A200806028A UA 99094 C2 UA99094 C2 UA 99094C2
Authority
UA
Ukraine
Prior art keywords
patients
treatment
positive disease
autoantibody positive
relates
Prior art date
Application number
UAA200806028A
Other languages
English (en)
Ukrainian (uk)
Inventor
Марк Червир
Уилльям Фримут
Чженшао Чжун
Дениэл Оденхеймер
Мелисса Д. Перкинс
Original Assignee
Хьюман Дженом Сайенсиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хьюман Дженом Сайенсиз, Инк. filed Critical Хьюман Дженом Сайенсиз, Инк.
Publication of UA99094C2 publication Critical patent/UA99094C2/ru

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Данное изобретение относится к способу лечения пациента с системной красной волчанкой, имеющего титр антиядерного антитела (ANA) ≥1:80 или уровень антител к дцДНК ≥30 МЕ/мл в его/ее плазме или сыворотке крови, который включает введение терапевтически эффективного количества антитела к нейтрокину-альфа.
UAA200806028A 2005-10-13 2006-10-05 Способ лечения пациента с системной красной волчанкой UA99094C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72562505P 2005-10-13 2005-10-13

Publications (1)

Publication Number Publication Date
UA99094C2 true UA99094C2 (ru) 2012-07-25

Family

ID=41003475

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200806028A UA99094C2 (ru) 2005-10-13 2006-10-05 Способ лечения пациента с системной красной волчанкой

Country Status (3)

Country Link
CN (1) CN101512007A (ru)
CR (1) CR9968A (ru)
UA (1) UA99094C2 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102533996B (zh) * 2012-01-04 2013-06-05 南通大学附属医院 确定人april基因启动子、转录因子结合位点的方法及用途
CN105732803A (zh) * 2014-07-13 2016-07-06 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA6及其应用
CN105732799A (zh) * 2014-07-13 2016-07-06 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA18及其应用
CN105693847A (zh) * 2014-07-13 2016-06-22 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA9及其应用
CN104177488B (zh) * 2014-07-13 2016-09-14 北京博奥医学检验所有限公司 一种特异性针对Neutrokine-α蛋白的核酸适配体及其应用
CN105693849A (zh) * 2014-07-13 2016-06-22 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA5及其应用
CN105732800A (zh) * 2014-07-13 2016-07-06 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA15及其应用
CN105693848A (zh) * 2014-07-13 2016-06-22 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA7及其应用
CN105732804A (zh) * 2014-07-13 2016-07-06 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA4及其应用
CN105713083A (zh) * 2014-07-13 2016-06-29 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA17及其应用
CN105693846A (zh) * 2014-07-13 2016-06-22 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA10及其应用
CN105732801A (zh) * 2014-07-13 2016-07-06 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA13及其应用
CN105732802A (zh) * 2014-07-13 2016-07-06 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA11及其应用
CN105753967A (zh) * 2014-07-13 2016-07-13 马海龙 一种特异性针对Neutrokine-α蛋白的核酸适配体NKXA14及其应用
US10039826B2 (en) * 2015-02-09 2018-08-07 Ucb Biopharma Sprl Pharmaceutical formulation comprising antibodies which bind colony stimulating factor-1 receptor (CSF1R)
CN113075400B (zh) * 2021-03-29 2022-07-22 广州市妇女儿童医疗中心 抗双链dna抗体作为先天性巨结肠诊断标志物的应用
CN113075410B (zh) * 2021-03-29 2022-08-16 广州市妇女儿童医疗中心 抗nRNP/Sm抗体作为先天性巨结肠诊断标志物的应用

Also Published As

Publication number Publication date
CR9968A (es) 2008-08-18
CN101512007A (zh) 2009-08-19

Similar Documents

Publication Publication Date Title
NZ597082A (en) Methods and Compositions for Use in Treatment of Patients with Autoantibody Positive Diseases
UA99094C2 (ru) Способ лечения пациента с системной красной волчанкой
UA101309C2 (ru) Антагонисты активина-actrii и их применение для повышения уровня эритроцитов
LUC00011I1 (ru)
SG146653A1 (en) Methods and reagents for the treatment of immunoinflammatory disorders
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
WO2007113648A3 (en) Ctla4 antibody combination therapy
TW200630093A (en) Dose forms
WO2004043341A3 (en) Treatment for hemorrhagic shock
MY162179A (en) Steroid sparing agents and methods of using same
WO2004103297A3 (en) Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
MA27699A1 (fr) Vaccin contre vhc
TW200806293A (en) Methods of treatment with CETP inhibitors
EA200800397A1 (ru) Композиции тизанидина и способы лечения с применением композиций
WO2007056301A3 (en) Antibody therapy for treatment of diseases associated with gluten intolerance
WO2006137938A3 (en) Antibody fragments for protection from pathogen infection and methods of use thereof
WO2008060535A3 (en) Use of reversine and analogs for treatment of cancer
WO2006044107A3 (en) Method of treating human preeclampsia employing resibufagenin
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
UA103907C2 (ru) Терапевтический режим лечения гепатита, который включает пег-интерферон, рибавирин и vx-950
TW200500073A (en) Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof
WO2003032895A3 (en) Methods and pharmaceutical compositions for stimulating the immune system and/or treating cancer
UA70188C2 (en) Method for treating patients with chronic cardiac insufficiency